Wearable Health Solutions, Inc. (WHSI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 8555.00 USD | 21.11% |
| 2022 | 7064.00 USD | -68.86% |
| 2021 | 22.68 Thousand USD | -78.96% |
| 2020 | 107.81 Thousand USD | 10.38% |
| 2019 | 97.67 Thousand USD | 7.0% |
| 2018 | 91.28 Thousand USD | -37.85% |
| 2017 | 146.89 Thousand USD | 1854.65% |
| 2016 | 7515.00 USD | -88.95% |
| 2015 | 67.99 Thousand USD | 197.71% |
| 2014 | 22.83 Thousand USD | -12.61% |
| 2013 | 26.13 Thousand USD | -49.78% |
| 2012 | 52.04 Thousand USD | 131.69% |
| 2011 | 22.46 Thousand USD | -68.51% |
| 2010 | 71.32 Thousand USD | 0.0% |
| 2009 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 8555.00 USD | 0.0% |
| 2024 Q2 | 5120.00 USD | -40.15% |
| 2023 FY | 8555.00 USD | 21.11% |
| 2023 Q1 | 41.19 Thousand USD | 483.18% |
| 2023 Q4 | 8555.00 USD | -74.29% |
| 2023 Q3 | 33.28 Thousand USD | -48.14% |
| 2023 Q2 | 64.17 Thousand USD | 55.77% |
| 2022 FY | 7064.00 USD | -68.86% |
| 2022 Q1 | - USD | -100.0% |
| 2022 Q2 | 1680.00 USD | 0.0% |
| 2022 Q3 | 16.19 Thousand USD | 864.11% |
| 2022 Q4 | 7064.00 USD | -56.39% |
| 2021 Q3 | - USD | 0.0% |
| 2021 FY | 22.68 Thousand USD | -78.96% |
| 2021 Q4 | 22.68 Thousand USD | 0.0% |
| 2021 Q1 | 137.47 Thousand USD | 0.0% |
| 2020 Q3 | 51.61 Thousand USD | 735.94% |
| 2020 FY | 107.81 Thousand USD | 10.38% |
| 2020 Q1 | 40.84 Thousand USD | -58.18% |
| 2020 Q2 | 6174.00 USD | -84.89% |
| 2020 Q4 | - USD | -100.0% |
| 2019 Q3 | 97.67 Thousand USD | 0.0% |
| 2019 FY | 97.67 Thousand USD | 7.0% |
| 2019 Q2 | 97.67 Thousand USD | 0.0% |
| 2019 Q1 | 97.67 Thousand USD | 7.0% |
| 2019 Q4 | 97.67 Thousand USD | 0.0% |
| 2018 Q1 | 151.69 Thousand USD | 3.27% |
| 2018 FY | 91.28 Thousand USD | -37.85% |
| 2018 Q4 | 91.28 Thousand USD | 571.72% |
| 2018 Q3 | 13.59 Thousand USD | -85.96% |
| 2018 Q2 | 96.82 Thousand USD | -36.17% |
| 2017 Q4 | 146.89 Thousand USD | -0.07% |
| 2017 Q3 | 146.99 Thousand USD | 11968.14% |
| 2017 Q2 | 1218.00 USD | -81.23% |
| 2017 Q1 | 6488.00 USD | -13.67% |
| 2017 FY | 146.89 Thousand USD | 1854.65% |
| 2016 Q4 | 7515.00 USD | -88.03% |
| 2016 Q2 | 51.38 Thousand USD | 35.47% |
| 2016 Q1 | 37.93 Thousand USD | -44.22% |
| 2016 Q3 | 62.76 Thousand USD | 22.15% |
| 2016 FY | 7515.00 USD | -88.95% |
| 2015 Q3 | 113.99 Thousand USD | -5.4% |
| 2015 Q4 | 67.99 Thousand USD | -40.35% |
| 2015 Q1 | 23.35 Thousand USD | 2.26% |
| 2015 FY | 67.99 Thousand USD | 197.71% |
| 2015 Q2 | 120.49 Thousand USD | 415.92% |
| 2014 Q3 | 6919.00 USD | -78.33% |
| 2014 FY | 22.83 Thousand USD | -12.61% |
| 2014 Q4 | 22.83 Thousand USD | 230.09% |
| 2014 Q2 | 31.92 Thousand USD | -61.2% |
| 2014 Q1 | 82.27 Thousand USD | 214.81% |
| 2013 Q1 | 52.04 Thousand USD | 0.0% |
| 2013 Q2 | 35.54 Thousand USD | -31.7% |
| 2013 Q3 | 1271.00 USD | -96.42% |
| 2013 Q4 | 26.13 Thousand USD | 1956.33% |
| 2013 FY | 26.13 Thousand USD | -49.78% |
| 2012 Q2 | 11.92 Thousand USD | -17.72% |
| 2012 Q3 | 9811.00 USD | -17.73% |
| 2012 Q4 | 52.04 Thousand USD | 430.45% |
| 2012 FY | 52.04 Thousand USD | 131.69% |
| 2012 Q1 | 14.49 Thousand USD | -35.48% |
| 2011 Q1 | 44.66 Thousand USD | -37.38% |
| 2011 Q2 | 43.68 Thousand USD | -2.19% |
| 2011 Q4 | 22.46 Thousand USD | 1.34% |
| 2011 FY | 22.46 Thousand USD | -68.51% |
| 2011 Q3 | 22.16 Thousand USD | -49.26% |
| 2010 Q2 | 52.74 Thousand USD | 0.0% |
| 2010 FY | 71.32 Thousand USD | 0.0% |
| 2010 Q4 | 71.32 Thousand USD | -24.1% |
| 2010 Q3 | 93.96 Thousand USD | 78.16% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | 93.608% |
| Ansell Limited | 457.04 Million USD | 99.998% |
| Ansell Limited | 457.9 Million USD | 99.998% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | 99.98% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | 69.326% |
| Psykey, Inc. | 49.94 Thousand USD | 82.869% |
| ConvaTec Group Plc | 395.54 Million USD | 99.998% |
| ConvaTec Group Plc | 396.1 Million USD | 99.998% |
| Encision Inc. | 1.4 Million USD | 99.39% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 192.049% |
| LifePoint, Inc. | 2.3 Million USD | 99.63% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | 99.644% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | 98.06% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | 90.689% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | 99.12% |
| SmileDirectClub, Inc. | 49.87 Million USD | 99.983% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 99.998% |
| SheerVision, Inc. | 339.66 Thousand USD | 97.481% |
| United Health Products, Inc. | 33.59 Thousand USD | 74.537% |
| Vasamed, Inc. | 449.02 Thousand USD | 98.095% |
| Yubo International Biotech Limited | 322.17 Thousand USD | 97.345% |